November’s 5% pullback is all but over now. With 0.6% left to go for a new all-time high, it seems like almost a certainty. December is traditionally a friendly month for investors, so I expect the ...

Discover why Invesco Food & Beverage ETF (PBJ) is a contrarian buy for 2026. Explore its defensive value and dividend ...

Discover why Nuveen NASDAQ 100 Dynamic Overwrite Fund (QQQX) is a top buy for income investors with an 8% yield and a rare 10 ...

Dow faces weak demand and excess capacity, but ongoing plant closures and cost cuts are gradually restoring industry balance.

Nutex Health recently posted Q2 and Q3 results, showing strong revenue growth and operating cash flow. Read why NUTX stock is ...

Discover why Montrose Environmental Group (MEG) is rated a Buy, with strong earnings, growth potential, and undervalued ...

Google's TPU chips position it as a viable Nvidia competitor, targeting a significant share of the AI data center market.

Grab Holdings' adjusted EBITDA and free cash flow have grown significantly. Click here to read more about GRAB stock and why ...

Syndax Pharmaceuticals posted strong Q3 results, driven by robust Revuforj and Niktimvo sales, despite a slight revenue miss.

I found DIVB's key strengths were on cost, diversification, and value, while it lags behind on growth and quality. Read why ...

This is my latest article, where I provide predictions of upcoming dividend increases from companies with long-term dividend ...

After the S&P 500's big November reversal, history suggests December will likely be green too. Read more here.